Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension

BACKGROUND/AIMS: Angiotensin receptor blockers (ARBs) inhibit activated hepatic stellate cell contraction and are thought to reduce the dynamic portion of intrahepatic resistance. This study compared the effects of combined treatment using the ARB candesartan and propranolol versus propranolol monot...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jae Hyun, Kim, Jung Min, Cho, Youn Zoo, Na, Ji Hoon, Kim, Hyun Sik, Kim, Hyoun A, Kang, Hye Won, Baik, Soon Koo, Kwon, Sang Ok, Cha, Seung Hwan, Kim, Young Ju, Kim, Moon Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278069/
https://www.ncbi.nlm.nih.gov/pubmed/25548744
http://dx.doi.org/10.3350/cmh.2014.20.4.376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278069/
https://www.ncbi.nlm.nih.gov/pubmed/25548744
http://dx.doi.org/10.3350/cmh.2014.20.4.376

Ejemplares similares